No Detail Found!

In silico analysis to reveal underlying trans differentiation mechanism of Mesenchymal Stem Cells into Osteocytes

Author(s)
Muhammad Shahid Javaid Centre of Excellence in Molecular Biology,University of the Punjab,West Canal Bank Road, Lahore , Pakistan
Haiba Kaul University of Veterinary and Animal Sciences,Lahore, Punjab -,PakistanAuthors' Affiliation:,Lahore, Punjab -,Pakistan
Numan Fazal Centre of Excellence in Molecular Biology, University of the Punjab,87 West Canal Bank Road, Lahore -,Pakistan
Faiza Yaqub Centre of Excellence in Molecular Biology, University of the Punjab,87 West Canal Bank Road, Lahore -,Pakistan
Nadia Naseer Centre of Excellence in Molecular Biology, University of the Punjab,87 West Canal Bank Road, Lahore -,PakistanAuthors' Affiliation:,87 West Canal Bank Road, Lahore -,Pakistan
Muzaffar Hanif Centre of Excellence in Molecular Biology, University of the Punjab,87 West Canal Bank Road, Lahore -,Pakistan
Noreen Latief Centre of Excellence in Molecular Biology, University of the Punjab,87 West Canal Bank Road, Lahore ,Pakistan
Abstract
Background: Bone is a mineralized dynamic tissue, helps to protect and support the body. Osteoarthritisdamages the cartilage and is responsible for the degeneration of the bone. Many cell-based therapies areavailable to repair the damage however, the non-availability of autologous cells and slows healing duringregeneration of the damaged bone present major constraints. Hence, there is a need to search for a convenientand easily available cell source that can not only be used to repair the bone but can also enhance its regenerativepotential. β-glycerophosphate, dexamethasone, and L-ascorbic-2-phosphate can differentiate mesenchymalstem cells (MSCs) into osteocytes. So far, the interaction of these compounds with osteocytes-specific proteinshas not been studied. In this study, in silico analysis was performed to investigate the interaction of proteinswith osteocytes specific compounds at the amino acids level.Methods: 3D structures of Dexamethasone and L-ascorbic-2-phosphate (ascorbic acid) were drawn usingMolecular Operating Environment (MOE). Then absorption, distribution, metabolism, and excretion (ADME)analysis was achieved using an online tool of “Swiss Package”. By Ramachandran plot, the predicted model ofALPL, MMP13, Osteonectin, and RunX2 proteins were evaluated. Then docking of these proteins withDexamethasone and L-ascorbic-2-phosphate was performed.Results: L-ascorbic-2-phosphate and Dexamethasone docked within the binding pockets of ALPL, RunX2,MMP13, and Osteonectin proteins, expressed in the bone cells. These compounds also showed good druglikeness and pharmacokinetics properties.Conclusion: It is concluded that β-glycerophosphate, dexamethasone, and L-ascorbic-2-phosphate are novelsubstrates for osteogenic differentiation. These compounds could increase the healing and regenerativepotential of bone cells by enhancing the expression of osteocytes specific proteins
Publication Details
Page(s) 412-418
DOI DOI not available
Published Journal: Advancements in life sciences, Volume: 8, Issue: 4, Year: 2021

Request the full text from PASTIC

Keywords
Osteoarthritis, Bone, docking, Dexamethasone, Mesenchymal stem cells (MSCs), Differentiation, ßglycerophosphate, Osteonectin, L-ascorbic2-phosphate
0

Citations

0

Downloads

29

Views